Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀåÀº 2024³â 39¾ï 1,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ µ¿¾È 5.70%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 54¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Æ®·£½ºµà¼(ÃÊÀ½ÆÄ ÇÁ·Îºê)´Â ÃÊÀ½ÆÄ À̹Ì¡ ½Ã½ºÅÛÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼ÒÀÔ´Ï´Ù. Àü±â ¿¡³ÊÁö¸¦ À½ÆÄ·Î º¯È¯Çϰųª ¹Ý´ë·Î À½ÆÄ¸¦ Àü±â ¿¡³ÊÁö·Î º¯È¯ÇÏ¿© ½Åü ±¸Á¶ÀÇ ³»ºÎ¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù. °íÁÖÆÄ À½ÆÄ´Â ÇÁ·Îºê¿¡¼ ¹æÃâµÇ¾î ½ÅüÀÇ Àå±â¿Í Á¶Á÷¿¡ ¹Ý»çµË´Ï´Ù. ¶ÇÇÑ ÇÁ·Îºê´ÂÀÌ ¿¡ÄÚ¸¦ Æ÷ÂøÇÏ¿© Àü±â ½ÅÈ£·Î º¯È¯ÇϰíÀ̸¦ ó¸®ÇÏ¿© °íÈÁú À̹ÌÁö¸¦ »ý¼ºÇÕ´Ï´Ù. ÃÊÀ½ÆÄ ÇÁ·Îºê´Â ´Ù¾çÇÑ Å©±â¿Í ¸ð¾çÀ¸·Î Á¦°øµÇ¸ç °¢°¢ Ç÷°ü, ½ÉÀå, º¹ºÎ µî ƯÁ¤ ¿ëµµ¿¡ ¸Â°Ô ¼³°èµÇ¾ú½À´Ï´Ù.
¹Ì±¹½ÉÀåÇùȸ¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀ» ¿¹¹æÇϱâ À§Çؼ´Â °Ç°ÇÑ ½Ä½À°üÀ» À¯ÁöÇÏ°í ±ÔÄ¢ÀûÀÎ ¿îµ¿À» ÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù°í ÇÕ´Ï´Ù.
Àúħ½ÀÀû ±â¼ú¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡
¼¼°èÀûÀÎ Ãß¼¼·Î Àúħ½ÀÀû ½Ã¼úÀº ±âÁ¸ ¼ö¼ú ¹æ¹ýº¸´Ù ȸº¹ ±â°£ÀÌ Âª°í ÇÕº´ÁõÀÌ ÀûÀ¸¸ç ȯÀÚ ¿¹Èİ¡ ÁÁ±â ¶§¹®¿¡ Àúħ½ÀÀû ½Ã¼ú·ÎÀÇ ÀüȯÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÊÀ½ÆÄ À¯µµÇÏ ½Ã¼úÀº Ư¼ö ÇÁ·Îºê¸¦ »ç¿ëÇÏ¿© ¹Ù´Ã »ý°Ë, Ä«Å×ÅÍ »ðÀÔ µî Ä¡·á ºÎÀ§¸¦ Á¤È®ÇÏ°Ô Å¸°ÙÆÃÇÒ ¼ö ÀÖ¾î ½Ã¼úÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.
ÃÖ÷´Ü ÀåºñÀÇ Å͹«´Ï¾ø´Â °¡°Ý
°í±ÞÇü ÃÊÀ½ÆÄ ½Ã½ºÅÛ°ú ÇÁ·Îºê´Â ÀÇ·á ½Ã¼³, ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼´Â Ãʱâ ÀÚº» ºñ¿ë°ú Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ºñ¿ëÀÌ ¸¹ÀÌ µì´Ï´Ù. ƯÈ÷ ¿¹»êÀÌ ÇÑÁ¤µÈ ¼Ò±Ô¸ð Ŭ¸®´ÐÀ̳ª ÀÇ·á ½Ã¼³¿¡¼´Â ÀÌ·¯ÇÑ °æÁ¦Àû À庮ÀÌ µµÀÔ·üÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. ¶ÇÇÑ, ÃÊÀ½ÆÄ ¿µ»óÀ» Á¶ÀÛÇÏ°í ÆÇµ¶ÇÏ´Â Á÷¿øÀ» ±³À°ÇÏ´Â µ¥¿¡µµ ºñ¿ëÀÌ µé±â ¶§¹®¿¡ Àüü ºñ¿ëÀº ´õ¿í Áõ°¡ÇÕ´Ï´Ù.
POCUS(Point of Care Ultrasound) °³¹ß
ÀÀ±ÞÀÇ·á, ÁßȯÀÚ½Ç, 1Â÷ÀÇ·á µî ´Ù¾çÇÑ ÀÓ»ó »óȲ¿¡¼ ÇöÀåÁø´Ü¿ë ÃÊÀ½ÆÄ °Ë»ç(POCUS)´Â È޴뼺, ½Ç½Ã°£ ¿µ»ó ó¸® ´É·Â, Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÎÇØ Á¡Á¡ ´õ ³Î¸® º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÈÞ´ë¿ë ÈÞ´ë¿ë ÃÊÀ½ÆÄ Áø´Ü ÀåºñÀÇ µµÀÔÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °³¼±Çϰí, ±âÁ¸ ¿µ»ó Áø´Ü ¹æ½Ä°ú °ü·ÃµÈ ÀÇ·á ºñ¿ëÀ» Àý°¨Çϸç, ȯÀÚÀÇ Ä§´ë ¿·¿¡¼ ½Å¼ÓÇÑ Áø´Ü Æò°¡¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.
°¡°Ý ¹Î°¨µµ ¹× °æÀï ¾Ð·Â
°¡°Ý ¾Ð·ÂÀº ƯÈ÷ ºñ¿ëÀÌ Áß¿äÇÑ ÀÇ·á ȯ°æ¿¡¼ ¿©·¯ ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í ÃÊÀ½ÆÄ ÇÁ·Îºê Á¦Á¶¾÷ü °£ÀÇ Ä¡¿ÇÑ °æÀïÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. °¡°Ý °æÀïÀº ƯÈ÷ °íÀ¯ÇÑ ±â´ÉÀ̳ª ÷´Ü ±â¼úÀÌ ¾ø´Â »óÇ°ÈµÈ ÃÊÀ½ÆÄ ÇÁ·Îºê¸¦ ÆÇ¸ÅÇÏ´Â »ç¾÷ÀÚÀÇ °æ¿ì ½ÃÀå Á¡À¯À²°ú ¼öÀÍ·ü¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
Äڷγª19ÀÇ ´ëÀ¯ÇàÀº ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Ãʱ⿡´Â ¿Ü·¡ Áø·á ¹× ºñÀÀ±Þ ÀÇ·á ÀýÂ÷°¡ Å©°Ô °¨¼ÒÇÏ¿© ÃÊÀ½ÆÄ ÇÁ·Îºê ¹× ±âŸ ¿µ»ó Áø´Ü ±â¼úÀÇ Çʿ伺ÀÌ °¨¼ÒÇß½À´Ï´Ù. º´¿øÀº Àη ºÎÁ·, ÀÚ¿ø ÀçºÐ¹è, Àåºñ ¾÷±×·¹ÀÌµå ¹× ±¸¸Å ¿¬±â µî ´Ù¸¥ ¾÷¹« ¹®Á¦º¸´Ù Äڷγª19 Ä¡·á¿¡ ¿ì¼±¼øÀ§¸¦ µÎ¾î¾ß Çß½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý Áø´ÜÀ» À§ÇÑ ÈÞ´ë¿ë ÈÞ´ë¿ë ÃÊÀ½ÆÄ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¿ø°Ý ÀÇ·á ¹× POCUS(Point-of-Care Ultrasound) Æ®·»µå°¡ °¡¼ÓÈµÇ¸é¼ ´õ¿í °¡¼ÓȵǾú½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ÇÁ·Îºê ºÎ¹®ÀÌ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå¿¡¼ ÇÁ·Îºê ºÎ¹®ÀÌ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¿©±â¼´Â ÀÇ·á¿ë ¿µ»óÁø´Ü ¹× Áø´Ü¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ À¯ÇüÀÇ ÃÊÀ½ÆÄ ÇÁ·Îºê¿¡ ´ëÇØ »ìÆìº¾´Ï´Ù. ÃÊÀ½ÆÄ ÇÁ·Îºê´Â ÀÇ·áÁøÀÌ Àý°³ ¾øÀÌ ³»ºÎ Àå±â¿Í Á¶Á÷À» º¼ ¼ö ÀÖµµ·Ï ÇÏ´Â ÃÊÀ½ÆÄ °Ë»ç ½Ã½ºÅÛÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼ÒÀÔ´Ï´Ù. ¶ÇÇÑ, ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿µ»óÈ ´É·Â, ÇØ»óµµ, È޴뼺ÀÌ Çâ»óµÈ ÇÁ·Îºê°¡ °³¹ßµÇ¾î ÇöÀç Áø·á¼Ò, º´¿ø, ¿ø°ÝÁö µî ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇ´Â ¹«¼± ÃÊÀ½ÆÄ ÇÁ·Îºê ºÐ¾ß
ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå¿¡¼ ¹«¼± ÃÊÀ½ÆÄ ÇÁ·Îºê ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â Àü ¼¼°è ÀÇ·á ȯ°æ¿¡¼ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÖ½À´Ï´Ù. ¹«¼± ÃÊÀ½ÆÄ ÇÁ·Îºê´Â À¯¼± ÃÊÀ½ÆÄ ÇÁ·Îºê¿¡ ºñÇØ À¯¿¬¼º°ú À̵¿¼ºÀÌ ¶Ù¾î³ª ÀÇ·áÁøÀÌ º¸´Ù Æí¸®Çϰí È¿À²ÀûÀ¸·Î ½ºÄµÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«¼± ±â¼úÀÇ ¹ßÀüÀ¸·Î ¹«¼± ÃÊÀ½ÆÄ ÇÁ·ÎºêÀÇ Ç°Áú°ú ½Å·Ú¼ºÀÌ Çâ»óµÇ¸é¼ ¹«¼± ÃÊÀ½ÆÄ ÇÁ·ÎºêÀÇ º¸±ÞÀÌ ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì°¡ ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§ÀÇ ÁÖ¿ä ¿äÀÎÀº Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó, ±â¼ú Çõ½ÅÀÇ ºü¸¥ µµÀÔ, ÀÇ·á R&D¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ¿¡ ±âÀÎÇÕ´Ï´Ù. ÃÊÀ½ÆÄ ÇÁ·Îºê¿Í °°Àº ÃֽŠÀÇ·á±â±â ¹× Áø´Ü µµ±¸´Â ºÏ¹Ì, ƯÈ÷ ¹Ì±¹¿¡¼ ³ôÀº ¼ö¿ä¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÌ ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀåÀ» ¼±µµÇÏ´Â ¹è°æ¿¡´Â À¯¸®ÇÑ »óȯ Á¤Ã¥°ú Á¶±â Áø´Ü ¹× ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀÌ ÀÖ½À´Ï´Ù.
ÃÊÀ½ÆÄ ÇÁ·Îºê ½ÃÀå¿¡¼ ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Àå ³ôÀº CAGRÀ» º¸À̰í ÀÖ½À´Ï´Ù. ÀÇ·áºñ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¼±, Á¶±â Áø´Ü ¹× Áúº´ ¿¹¹æ¿¡ ´ëÇÑ ´ëÁßÀÇ ÀÎ½Ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀÎÀÌ ÀÌ·¯ÇÑ ºü¸¥ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ÁÖ¿ä ±¹°¡·Î´Â Áß±¹, Àεµ, ÀϺ», Çѱ¹ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÚµåÇïµå ¹× ÈÞ´ë¿ë ÃÊÀ½ÆÄ Áø´Ü ÀåºñÀÇ º¸±Þ°ú °°Àº ±â¼ú °³¹ßÀÌ ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå È®´ë¸¦ °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Ultrasound Probes Market is accounted for $3.91 billion in 2024 and is expected to reach $5.45 billion by 2030 growing at a CAGR of 5.70% during the forecast period. Transducers, or ultrasound probes, are crucial parts of ultrasound imaging systems. By converting electrical energy into sound waves and vice versa, these gadgets make it possible to see inside bodily structures. High-frequency sound waves are emitted by the probe and bounce off organs and tissues inside the body. Moreover, the probe picks up these echoes and transforms them back into electrical signals, which are then processed to produce finely detailed pictures. Ultrasound probes are available in a range of sizes and forms, each designed for a particular use, such as vascular, cardiac, or abdominal imaging.
According to the American Heart Association, maintaining a healthy diet and regular physical activity are crucial in preventing cardiovascular diseases.
Increasing requirement for less invasive techniques
Globally, there is a trend toward less invasive procedures because they are associated with shorter recovery periods, fewer complications, and better patient outcomes than conventional surgical methods. Additionally, the use of specialized probes in ultrasound-guided procedures allows for precise targeting of treatment areas, such as needle biopsies or catheter placements, thereby improving procedural safety and efficacy.
Exorbitant price of cutting-edge equipment
High-end ultrasound systems and probes can come with significant upfront capital costs and ongoing maintenance costs for medical facilities, particularly in areas with limited resources. Adoption rates are hampered by this financial barrier, especially in smaller clinics and healthcare facilities with tighter budgets. Furthermore, the overall cost is further increased by the expense of training staff members to operate and interpret ultrasound images.
Development of point-of-care ultrasonography (POCUS)
In a variety of clinical contexts, such as emergency medicine, critical care, and primary care, point-of-care ultrasound (POCUS) is becoming more and more popular because of its portability, real-time imaging capabilities, and affordability. Moreover, incorporating portable and handheld ultrasound devices improves clinical decision-making, lowers healthcare costs related to traditional imaging modalities, and allows for rapid diagnostic assessments at the patient's bedside.
Price sensitivity and competitive pressure
Price pressure arises from the presence of multiple market players and intense competition among ultrasound probe manufacturers, especially in healthcare environments where costs are critical. Additionally, price competition can have an impact on market share and profit margins, particularly for businesses selling commoditized ultrasound probes that lack unique features or cutting-edge technology.
The COVID-19 pandemic had a major effect on the market for ultrasound probes. There was initially a significant drop in outpatient visits and non-urgent medical procedures, which decreased the need for ultrasound probes and other diagnostic imaging technologies. Hospitals had to prioritize COVID-19 treatment over other operational issues, such as staffing shortages, resource reallocation, and equipment upgrades and purchases being delayed. Furthermore, the need for portable and handheld ultrasound devices for remote diagnostics was fueled by the pandemic's acceleration of telemedicine and point-of-care ultrasound (POCUS) trends.
The Probe segment is expected to be the largest during the forecast period
The probe segment has the largest share in the ultrasound probe market. This section covers the different kinds of ultrasound probes that are used in imaging and diagnostics in medicine. Ultrasound probes are vital parts of ultrasonography systems that allow medical professionals to view internal organs and tissues without making any incisions. Moreover, the development of probes with improved imaging capabilities, greater resolutions, and greater portability has been made possible by technological advancements, and these probes can now be used in a variety of medical settings, including clinics, hospitals, and even remote areas.
The Wireless Ultrasound Probe segment is expected to have the highest CAGR during the forecast period
Within the ultrasound probe market, the wireless ultrasound probe segment exhibits the highest CAGR. Numerous factors driving demand in healthcare settings globally can be attributed to this growth. Compared to their wired counterparts, wireless ultrasound probes are more flexible and mobile, which makes scanning more convenient and efficient for medical professionals. Additionally, the quality and dependability of wireless ultrasound probes have also improved due to advancements in wireless technology, which has fueled their adoption even more.
North America holds the largest market share for ultrasound probes. The primary factors contributing to this dominance are the sophisticated healthcare infrastructure, the rapid adoption of technological innovations, and the significant investments made in healthcare R&D. Modern medical equipment and diagnostic tools, such as ultrasound probes, are in high demand in North America, especially in the United States. Furthermore, the region leads the ultrasound probe market in part because of advantageous reimbursement policies and a proactive approach to early diagnosis and preventive healthcare.
In the ultrasound probe market, the Asia-Pacific region has the highest CAGR. Numerous factors, such as rising healthcare costs, growing healthcare infrastructure, and growing public awareness of early diagnosis and disease prevention, are contributing to this rapid growth. Key players in this growth include China, India, Japan, and South Korea. Furthermore, technological developments like the widespread use of handheld and portable ultrasound equipment are hastening market expansion in the Asia-Pacific area.
Key players in the market
Some of the key players in Ultrasound Probes market include GE Healthcare, Hitachi Medical Systems, Fujifilm Holdings Corporation, RamSoft, Inc., Samsung Electronics Co., Ltd., Esaote SpA, Analogic Corporation, Healcerion Co., Ltd., Canon Medical Systems, Siemens Healthcare GmbH , Terason Corporation, Philips Healthcare, Trivitron Healthcare, Akumin Inc., Koninklijke Philips N.V. , Hologic Inc. , Toshiba Corporation and Sonic Healthcare Limited.
In April 2024, FUJIFILM Wako Chemicals U.S.A. Corporation (Fujifilm), a supplier of high purity chemicals and reagents, and Predictive Oncology Inc., , a leader in AI-driven drug discovery and biologics, announced that the companies have entered into a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US.The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices.
In April 2023, Philips Healthcare has secured a contract to provide its HealthSuite Imaging PACS to Amazon Web Services (AWS).The deal builds on an existing arrangement between Philips and AWS that includes Amazon Bedrock for cloud-based artificial intelligence (AI) applications that support clinical decision-making, Philips said.